Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12005097 Aflibercept formulations and uses thereof

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Jun, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 12 Jun, 2024
Edits made to:
Infobox (+40 properties)
Article (+192 characters)
‌

 US Patent 12005097 Aflibercept formulations and uses thereof

Article

Patent abstract

Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.

Infobox
Is a
Patent
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120050970
Patent Inventor Names
Alison J. Gillespie0
Bruce A. Kerwin0
Christine C Siska0
Julee A. Floyd0
Date of Patent
June 11, 2024
0
Patent Application Number
174926490
Date Filed
October 3, 2021
0
Patent Citations
‌
US Patent 7303746 Methods of treating eye disorders with modified chimeric polypeptides
0
‌
US Patent 7303747 Use of VEGF inhibitors for treatment of eye disorders
0
‌
US Patent 7306799 Use of VEGF inhibitors for treatment of eye disorders
0
‌
US Patent 7374757 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 7374758 Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof
0
‌
US Patent 7521049 Use of VEGF inhibitors for treatment of eye disorders
0
‌
US Patent 7524499 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 8029791 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 8092803 VEGF antagonist formulations for intravitreal administration
0
‌
US Patent 8110546 VEGF antagonist formulations
0
‌
US Patent 8133863 Stabilizing alkylglycoside compositions and methods thereof
0
‌
US Patent 8343737 Cell culture compositions capable of producing a VEGF-binding fusion polypeptide
0
‌
US Patent 8372396 Antibody formulations
0
‌
US Patent 8404638 Dimer VEGF antagonist formulations
0
‌
US Patent 8647842 Methods for producing a fusion protein capable of binding VEGF
0
‌
US Patent 8710004 Stable liquid VEGF antagonist formulations
0
‌
US Patent 8921316 Stable liquid VEGF antagonist formulations
0
‌
US Patent 9139644 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 9254338 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 9364542 Protein formulations containing amino acids
0
‌
US Patent 9416167 Stable liquid formulations of dimer VEGF antagonists
0
‌
US Patent 9511140 Stable VEGF antagonist formulations
0
‌
US Patent 9580489 VEGF antagonist formulations suitable for intravitreal administration
0
‌
US Patent 9636400 VEGF specific fusion protein antagonist formulations
0
‌
US Patent 9669069 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 9708386 Modified chimeric polypeptides with improved pharmacokinetic properties
0
‌
US Patent 9982032 Stable liquid formulation of fusion protein with IgG Fc domain
0
‌
US Patent 10130681 Use of a VEGF antagonist to treat angiogenic eye disorders
0
‌
US Patent 7070959 Modified chimeric polypeptides with improved pharmacokinetic properties
0
Patent Primary Examiner
‌
Christine J. Saoud
0

Find more entities like US Patent 12005097 Aflibercept formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo